Relationship Between Baseline and Early Changes in C‐Reactive Protein and Interleukin‐6 Levels and Clinical Response to Tocilizumab in Rheumatoid Arthritis

por Wang, Jianmei, Devenport, Jenny, Low, Jason M., Yu, Dale, Hitraya, Elena
Publicado 2016

Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs

por Rigby, William F. C., Lampl, Kathy, Low, Jason M., Furst, Daniel E.
Publicado 2017

Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis

por Reiss, William G., Devenport, Jenny N., Low, Jason M., Wu, George, Sasso, Eric H.
Publicado 2015